Lobetron 0.5mg Tablet

About this Medicine

Lobetron 0.5mg Tablet is used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. This helps prevent serious complications of diabetes like kidney damage and blindness. Lobetron 0.5mg Tablet may be used alone or along with other medicines. It may be taken with or without food. However, take it regularly at the same time each day to get the most benefits. Your doctor will decide what dose is best for you and this may change from time to time according to this drug’s effect on you.Keep taking Lobetron 0.5mg Tablet, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting the doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems, and loss of limbs. Remember that it is only a part of the treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by the doctor. Your lifestyle plays a big part in controlling diabetes.The most common side effects of taking this medicine include edema, fatigue, and weight gain. Please consult your doctor if these bother you or persist for a longer duration.You should not take it if you have type 1 diabetes mellitus, diabetic ketoacidosis (high levels of acid in your blood), or severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease, thyroid disease, or some hormonal conditions. Pregnant or breastfeeding women should also consult their doctor before taking it. Get your blood sugar levels checked regularly, and your doctor may also advise blood tests to monitor your blood cell counts and liver function.

How it Works

Lobetron 0.5mg Tablet works as an insulin sensitizer by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.

Key Facts

Chemical Class :: Diarylethers|Habit Forming :: No|Therapeutic Class :: ANTI DIABETIC|Action Class :: Thiazolidinediones (TZD) and PPAR Gamma Agonists

Safety Overview